AMAZELIFE GLOWY CAPSULE
AMAZELIFE GLOWY CAPSULE : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL23046082NC
- Type
- Health supplement
- Published status
- PRODUCT APPROVED
- Licence holder
- AMAZELIFE HEALTHCARE SDN BHD
- Manufacturer
- Esprit Care Sdn. Bhd.
- Registration date
- 2023-04-18
- Published validity end
- 2028-04-18
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| CALCIUM ASCORBATE DIHYDRATE | CALCIUM ASCORBATE DIHYDRATE[63.05 mg,460 mg] | Vitamine C |
| ZINC BISGLYCINATE | ZINC BISGLYCINATE[30 mg,460 mg] | Zinc |
| TAGETES ERECTA (MARIGOLD) EXTRACT | TAGETES ERECTA (MARIGOLD) EXTRACT[50 mg,460 mg] | Not identified |
| L-GLUTATHIONE | L-GLUTATHIONE[50 mg,460 mg] | Not identified |
| L-CYSTEINE HCL | L-CYSTEINE HCL[65.04 mg,460 mg] | Not identified |
| GRAPE SEED EXTRACT (VITIS VINIFERA) | GRAPE SEED EXTRACT (VITIS VINIFERA)[25 mg,460 mg] | Not identified |
| CUCUMIS MELO (MELON) CONCENTRATE | CUCUMIS MELO (MELON) CONCENTRATE[125 mg,460 mg] | Not identified |
| LYCOPERSICON ESCULENTUM (TOMATO) | LYCOPERSICON ESCULENTUM (TOMATO)[40 mg,460 mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- CALCIUM ASCORBATE DIHYDRATE[63.05 mg,460 mg],ZINC BISGLYCINATE[30 mg,460 mg],TAGETES ERECTA (MARIGOLD) EXTRACT[50 mg,460 mg],L-GLUTATHIONE[50 mg,460 mg],L-CYSTEINE HCL[65.04 mg,460 mg],GRAPE SEED EXTRACT (VITIS VINIFERA)[25 mg,460 mg],CUCUMIS MELO (MELON) CONCENTRATE[125 mg,460 mg],LYCOPERSICON ESCULENTUM (TOMATO)[40 mg,460 mg]
- Valid until
- 2028-04-18
- Registration date
- 2023-04-18
- Published description
- HEALTH SUPPLEMENT
- Licence holder
- AMAZELIFE HEALTHCARE SDN BHD
- Producer
- Esprit Care Sdn. Bhd.
- Published name
- AMAZELIFE GLOWY CAPSULE
- Published reference
- 202212199885N
- Registration number
- MAL23046082NC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL23046082NC
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.